Browse by UCL people
Group by: Type | Date
Number of items: 15.
Article
Chavda, SJ;
Maciocia, PM;
Mesiri, P;
Counsell, N;
Kothari, J;
Bird, A;
Mariner, C;
... Yong, K; + view all
(2019)
A new prognostic model for myeloma patients relapsing from upfront autologous transplantation based on ISS and PFS1.
British Journal of Haematology
, 185
(2)
pp. 350-353.
10.1111/bjh.15487.
|
|
Cwynarski, Kate;
Iacoboni, Gloria;
Tholouli, Eleni;
Menne, Tobias;
Irvine, David A;
Balasubramaniam, Nivetha;
Wood, Leigh;
... Pule, Martin; + view all
(2025)
TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trial.
Nature Medicine
, 31
pp. 137-143.
10.1038/s41591-024-03326-7.
|
|
Ferrari, Mathieu;
Parekh, Farhaan;
Maciocia, Paul;
Horna, Pedro;
Thomas, Simon;
Sewell, Andrew K;
Pule, Martin;
(2025)
Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies.
Nature Communications
, 16
, Article 1103. 10.1038/s41467-025-56396-7.
|
 |
|
Ferrari, Mathieu;
Righi, Matteo;
Baldan, Vania;
Wawrzyniecka, Patrycja;
Bulek, Anna;
Kinna, Alexander;
Ma, Biao;
... Pule, Martin; + view all
(2024)
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies.
Nature Communications
, 15
, Article 1583. 10.1038/s41467-024-45854-3.
|
|
Horna, Pedro;
Weybright, Matthew J;
Ferrari, Mathieu;
Jungherz, Dennis;
Peng, YaYi;
Akbar, Zulaikha;
Tudor Ilca, F;
... Olteanu, Horatiu; + view all
(2024)
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry.
Blood Cancer Journal
, 14
(1)
, Article 34. 10.1038/s41408-024-01002-0.
|
|
Lee, L;
Draper, B;
Chaplin, N;
Philip, B;
Chin, M;
Galas-Filipowicz, D;
Onuoha, S;
... Pule, M; + view all
(2017)
An APRIL based chimeric antigen receptor for dual targeting of BCMA and TACI in Multiple Myeloma.
Blood
, 2017
(5)
, Article 781351. 10.1182/blood-2017-05-781351.
|
|
Maciocia, N;
Spencer, D;
Maciocia, P;
Childerhouse, A;
O’Reilly, M;
Payne, E;
Roddie, C;
(2024)
Late onset pancytopenia post chimeric antigen receptor T cell therapy triggered by a COVID-19 vaccination: a case report.
Frontiers in Hematology
, 3
10.3389/frhem.2024.1435584.
(In press).
|
|
|
Maciocia, Nicola;
Hoekx, Malika;
Acuna, Ciaran;
Wade, Brandon;
Burley, Amy;
Ramanayake, Saumya;
Nannini, Francesco;
... Maciocia, Paul; + view all
(2025)
Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemia.
Science Translational Medicine
, 17
(794)
, Article eadr1476. 10.1126/scitranslmed.adr1476.
|
|
Maciocia, Nicola;
Wade, Brandon;
Maciocia, Paul;
(2025)
CAR T-cell therapies for T-cell malignancies: does cellular immunotherapy represent the best chance of cure?
Blood Advances
, 9
(4)
pp. 913-923.
10.1182/bloodadvances.2023012263.
|
|
|
Maciocia, Paul Michael;
Wawrzyniecka, Patrycja A;
Maciocia, Nicola C;
Burley, Amy;
Karpanasamy, Thaneswari;
Devereaux, Sam;
Hoekx, Malika;
... Mansour, Marc R; + view all
(2022)
Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia.
Blood
, 140
(1)
pp. 25-37.
10.1182/blood.2021013648.
|
|
Maciocia, N;
Melville, A;
Cheesman, S;
Sharpley, F;
Ramasamy, K;
Streetly, M;
Jenner, M;
... Rabin, N; + view all
(2017)
Real-world use of pomalidomide and dexamethasone in double refractory multiple myeloma suggests benefit in renal impairment and adverse genetics: a multi-centre UK experience.
British Journal of Haematology
, 176
(6)
pp. 908-917.
10.1111/bjh.14547.
|
|
|
Maciocia, PM;
Wawrzyniecka, PA;
Akarca, AU;
Philip, B;
Ricciardelli, I;
Somja, J;
Onuoha, SC;
... Pule, MA; + view all
(2017)
Targeting T-cell receptor β-constant region for immunotherapy of T-cell malignancies.
Nature Medicine
, 23
(12)
pp. 1416-1423.
10.1038/nm.4444.
|
|
Wawrzyniecka, PA;
Ibrahim, L;
Gritti, G;
Pule, MA;
Maciocia, PM;
(2021)
Chimeric antigen receptor T cells for gamma-delta T cell malignancies.
Leukemia
10.1038/s41375-021-01385-0.
(In press).
|
|
Conference item
|
Maciocia, PM;
Wawrzyniecka, P;
Philip, B;
Akarca, A;
Marafioti, T;
Pule, MA;
(2016)
Targeting the TCR beta-constant region for specific immunotherapy of T-cell malignancies.
Presented at: Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy, Florence, ITALY.
|
|
Thesis
|
Maciocia, PM;
(2017)
Targeting the T-cell Receptor Beta Constant Region for Investigation and Immunotherapy of T-cell Malignancies.
Doctoral thesis , UCL (University College London).
|
